Evidence map›Paper›PMID 39673553›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2024

Role of LIPIN 1 in regulating metabolic homeostasis in the retinal pigment epithelium.

Anna S Usoltseva, Christopher Litwin, Michael Lee, Colton Hill, Jiyang Cai, Yan Chen

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna S UsoltsevaDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID https://orcid.org/0009-0006-7707-2186
Christopher LitwinDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID https://orcid.org/0000-0001-6833-454X
Michael LeeCollege of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID https://orcid.org/0009-0008-7766-7846
Colton HillCollege of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID https://orcid.org/0009-0005-6471-2255
Jiyang CaiDepartment of Biochemistry and Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID https://orcid.org/0000-0003-4755-5452
Yan ChenDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID https://orcid.org/0000-0003-3672-8477

Funding

P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
mTORC1-TFEB pathway in degeneration of the RPER01EY026999 · NEI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CHEN, YAN · 2016 to 2025
$3.4M
Metabolic reprogramming of endothelial precursor cells in subretinal fibrosisR01EY034742 · NEI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI JIYANG CAI, Jian-Xing Jay Ma · 2023 to 2026
$1.8M
Choroidal Gamma Delta T Cells as Novel Regulators of RPE DegenerationR01EY028773 · NEI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CAI, JIYANG · 2018 to 2021
$1.8M
BrightFoucs Foundation M2017186Harold Hamm Diabetes CenterHHS | National Institutes of Health (NIH) P30EY027125HHS | National Institutes of Health (NIH) R01EY026999HHS | National Institutes of Health (NIH) R01EY028773HHS | National Institutes of Health (NIH) R01EY034742NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY026999NEI NIH HHS R01 EY028773NEI NIH HHS R01 EY034742Presbyterian Health Foundation (PHF)Research to Prevent BlindnessVitreoRetinal Surgery Foundation (VRSF)
6 · The paper itself

Abstract

Dysregulated lipid metabolism, characterized by the accumulation of lipid deposits on Bruch's membrane and in drusen, is considered a key pathogenic event in age-related macular degeneration (AMD). The imbalance of lipid production, usage, and transport in local tissues, particularly in the retinal pigment epithelium (RPE), is increasingly recognized as crucial in AMD development. However, the molecular mechanisms governing lipid metabolism in the RPE remain elusive. LIPIN1, a multifunctional protein acting as both a modulator of transcription factors and a phosphatidate phosphatase (PAP1), is known to play important regulatory roles in lipid metabolism and related biological functions, such as inflammatory responses. While deficits in LIPIN1 have been linked to multiple diseases, its specific roles in the retina and RPE remain unclear. In this study, we investigated LIPIN1 in RPE integrity and function using a tissue-specific knockout animal model. The clinical and histological examinations revealed age-dependent degeneration in the RPE and the retina, along with impaired lipid metabolism. Bulk RNA sequencing indicated a disturbance in lipid metabolic pathways. Moreover, these animals exhibited inflammatory markers reminiscent of human AMD features, including deposition of IgG and C3d on Bruch's membrane. Collectively, our findings indicate that LIPIN1 is a critical component of the complex regulatory network of lipid homeostasis in the RPE. Disruption of LIPIN1-mediated regulation impaired lipid balance and contributed to AMD-related pathogenic changes.

Indexed as

HomeostasisLipid MetabolismMice, KnockoutPhosphatidate PhosphataseRetinal Pigment EpitheliumAnimalsHumansMacular DegenerationMaleMiceMice, Inbred C57BLLpin1 protein, mousePhosphatidate Phosphataseage‐related macular degenerationlipidLipin1metabolismretinal pigment epithelium

Identifiers

PMID39673553
PMCPMC11809763

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.